Balyasny Asset Management LLC Regeneron Pharmaceuticals, Inc. Put Options Transaction History

Balyasny Asset Management LLC

  • $58 Billion
  • Q3 2024

Put Options

11 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$1024.09 - $1201.76 $3.99 Million - $4.69 Million
-3,900 Reduced 5.69%
64,600 $67.9 Million
Q2 2024

Aug 14, 2024
BUY
$883.2 - $1071.19 $5.03 Million - $6.11 Million
5,700 Added 9.08%
68,500 $72 Million
Q1 2024

May 13, 2024
SELL
$902.69 - $993.35 $4.51 Million - $4.97 Million
-5,000 Reduced 7.37%
62,800 $60.4 Million
Q4 2023

Feb 14, 2024
BUY
$775.18 - $881.7 $44.5 Million - $50.6 Million
57,400 Added 551.92%
67,800 $59.5 Million
Q3 2023

Nov 14, 2023
SELL
$692.45 - $844.37 $346,225 - $422,185
-500 Reduced 4.59%
10,400 $8.56 Million
Q2 2023

Aug 14, 2023
BUY
$700.03 - $830.35 $2.03 Million - $2.41 Million
2,900 Added 36.25%
10,900 $7.83 Million
Q4 2022

Feb 14, 2023
BUY
$705.89 - $766.39 $917,657 - $996,307
1,300 Added 19.4%
8,000 $5.77 Million
Q3 2022

Nov 14, 2022
BUY
$573.97 - $724.32 $3.04 Million - $3.84 Million
5,300 Added 378.57%
6,700 $4.62 Million
Q2 2022

Aug 15, 2022
BUY
$548.35 - $738.84 $767,690 - $1.03 Million
1,400 New
1,400 $828,000
Q3 2021

Nov 15, 2021
SELL
$574.03 - $680.96 $918,448 - $1.09 Million
-1,600 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$472.8 - $558.54 $756,480 - $893,664
1,600 New
1,600 $894,000

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email